
### [MONDO:0002884](http://purl.obolibrary.org/obo/MONDO_0002884)
**Label:** nail disease

**Subclasses:** [MONDO:0008061](http://purl.obolibrary.org/obo/MONDO_0008061) (nail-patella syndrome), [MONDO:0013596](http://purl.obolibrary.org/obo/MONDO_0013596) (nonsyndromic congenital nail disorder 10), [MONDO:0014324](http://purl.obolibrary.org/obo/MONDO_0014324) (pachyonychia congenita 3), [MONDO:0019577](http://purl.obolibrary.org/obo/MONDO_0019577) (anonychia-onychodystrophy syndrome), [MONDO:0001628](http://purl.obolibrary.org/obo/MONDO_0001628) (tinea unguium), [MONDO:0013592](http://purl.obolibrary.org/obo/MONDO_0013592) (nonsyndromic congenital nail disorder 9), [MONDO:0011595](http://purl.obolibrary.org/obo/MONDO_0011595) (nonsyndromic congenital nail disorder 7), [MONDO:0011034](http://purl.obolibrary.org/obo/MONDO_0011034) (Odontomicronychial dysplasia), [MONDO:0009079](http://purl.obolibrary.org/obo/MONDO_0009079) (DOORS syndrome), [MONDO:0008125](http://purl.obolibrary.org/obo/MONDO_0008125) (nonsyndromic congenital nail disorder 5), [MONDO:0019211](http://purl.obolibrary.org/obo/MONDO_0019211) (isolated congenital anonychia), [MONDO:0004616](http://purl.obolibrary.org/obo/MONDO_0004616) (herpetic whitlow), [MONDO:0018021](http://purl.obolibrary.org/obo/MONDO_0018021) (hypotrichosis-deafness syndrome), [MONDO:0016083](http://purl.obolibrary.org/obo/MONDO_0016083) (FLOTCH syndrome), [MONDO:0007900](http://purl.obolibrary.org/obo/MONDO_0007900) (nonsyndromic congenital nail disorder 3), [MONDO:0007867](http://purl.obolibrary.org/obo/MONDO_0007867) (nonsyndromic congenital nail disorder 2), [MONDO:0007921](http://purl.obolibrary.org/obo/MONDO_0007921) (yellow nail syndrome), [MONDO:0000073](http://purl.obolibrary.org/obo/MONDO_0000073) (nail disorder, nonsyndromic congenital), [MONDO:0007343](http://purl.obolibrary.org/obo/MONDO_0007343) (isolated congenital digital clubbing), [MONDO:0007420](http://purl.obolibrary.org/obo/MONDO_0007420) (autosomal dominant deafness-onychodystrophy syndrome), [MONDO:0011852](http://purl.obolibrary.org/obo/MONDO_0011852) (nonsyndromic congenital nail disorder 8), [MONDO:0010883](http://purl.obolibrary.org/obo/MONDO_0010883) (pectus excavatum-macrocephaly-dysplastic nails syndrome), [MONDO:0014325](http://purl.obolibrary.org/obo/MONDO_0014325) (pachyonychia congenita 4), [MONDO:0016213](http://purl.obolibrary.org/obo/MONDO_0016213) (leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome), [MONDO:0016557](http://purl.obolibrary.org/obo/MONDO_0016557) (leukonychia totalis), [MONDO:0008173](http://purl.obolibrary.org/obo/MONDO_0008173) (pachyonychia congenita 1), [MONDO:0008174](http://purl.obolibrary.org/obo/MONDO_0008174) (pachyonychia congenita 2), [MONDO:0009344](http://purl.obolibrary.org/obo/MONDO_0009344) (Hirschsprung disease-nail hypoplasia-dysmorphism syndrome), [MONDO:0019285](http://purl.obolibrary.org/obo/MONDO_0019285) (syndromic nail anomaly), [MONDO:0016471](http://purl.obolibrary.org/obo/MONDO_0016471) (pachyonychia congenita), [MONDO:0008798](http://purl.obolibrary.org/obo/MONDO_0008798) (nonsyndromic congenital nail disorder 4), [MONDO:0009822](http://purl.obolibrary.org/obo/MONDO_0009822) (Otoonychoperoneal syndrome), [MONDO:0019283](http://purl.obolibrary.org/obo/MONDO_0019283) (nail anomaly), [MONDO:0019284](http://purl.obolibrary.org/obo/MONDO_0019284) (isolated nail anomaly), [MONDO:0021028](http://purl.obolibrary.org/obo/MONDO_0021028) (genetic nail anomaly), [MONDO:0005898](http://purl.obolibrary.org/obo/MONDO_0005898) (paronychia (disease)), [MONDO:0009827](http://purl.obolibrary.org/obo/MONDO_0009827) (pachyonychia congenita, autosomal recessive), [MONDO:0007135](http://purl.obolibrary.org/obo/MONDO_0007135) (nonsyndromic congenital nail disorder 6), [MONDO:0007134](http://purl.obolibrary.org/obo/MONDO_0007134) (Cooks syndrome), [MONDO:0007131](http://purl.obolibrary.org/obo/MONDO_0007131) (anonychia with flexural pigmentation), [MONDO:0012735](http://purl.obolibrary.org/obo/MONDO_0012735) (Temple-Baraitser syndrome), [MONDO:0017922](http://purl.obolibrary.org/obo/MONDO_0017922) (deafness-onychodystrophy syndrome), [MONDO:0008060](http://purl.obolibrary.org/obo/MONDO_0008060) (nonsyndromic congenital nail disorder 1), 

**Mapped go classes:** [GO:0016404](http://purl.obolibrary.org/obo/GO_0016404) (15-hydroxyprostaglandin dehydrogenase (NAD+) activity), [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0045095](http://purl.obolibrary.org/obo/GO_0045095) (keratin filament), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0071805](http://purl.obolibrary.org/obo/GO_0071805) (potassium ion transmembrane transport), [GO:0005882](http://purl.obolibrary.org/obo/GO_0005882) (intermediate filament), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0060117](http://purl.obolibrary.org/obo/GO_0060117) (auditory receptor cell development), [GO:0031901](http://purl.obolibrary.org/obo/GO_0031901) (early endosome membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0042391](http://purl.obolibrary.org/obo/GO_0042391) (regulation of membrane potential), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:1900274](http://purl.obolibrary.org/obo/GO_1900274) (regulation of phospholipase C activity), [GO:1905962](http://purl.obolibrary.org/obo/GO_1905962) (glutamatergic neuron differentiation), [GO:0097070](http://purl.obolibrary.org/obo/GO_0097070) (ductus arteriosus closure), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0000160](http://purl.obolibrary.org/obo/GO_0000160) (phosphorelay signal transduction system), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0051546](http://purl.obolibrary.org/obo/GO_0051546) (keratinocyte migration), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0042048](http://purl.obolibrary.org/obo/GO_0042048) (olfactory behavior), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0051798](http://purl.obolibrary.org/obo/GO_0051798) (positive regulation of hair follicle development), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0035880](http://purl.obolibrary.org/obo/GO_0035880) (embryonic nail plate morphogenesis), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0045727](http://purl.obolibrary.org/obo/GO_0045727) (positive regulation of translation), [GO:0033340](http://purl.obolibrary.org/obo/GO_0033340) (pelvic fin development), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0033335](http://purl.obolibrary.org/obo/GO_0033335) (anal fin development), [GO:0035878](http://purl.obolibrary.org/obo/GO_0035878) (nail development), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0033338](http://purl.obolibrary.org/obo/GO_0033338) (medial fin development), [GO:0033337](http://purl.obolibrary.org/obo/GO_0033337) (dorsal fin development), [GO:0033336](http://purl.obolibrary.org/obo/GO_0033336) (caudal fin development), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0005200](http://purl.obolibrary.org/obo/GO_0005200) (structural constituent of cytoskeleton), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021592](http://purl.obolibrary.org/obo/GO_0021592) (fourth ventricle development), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007035](http://purl.obolibrary.org/obo/GO_0007035) (vacuolar acidification), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0021576](http://purl.obolibrary.org/obo/GO_0021576) (hindbrain formation), [GO:0004435](http://purl.obolibrary.org/obo/GO_0004435) (phosphatidylinositol phospholipase C activity), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0002930](http://purl.obolibrary.org/obo/GO_0002930) (trabecular meshwork development), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0001964](http://purl.obolibrary.org/obo/GO_0001964) (startle response), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0046961](http://purl.obolibrary.org/obo/GO_0046961) (proton-transporting ATPase activity, rotational mechanism), [GO:0048105](http://purl.obolibrary.org/obo/GO_0048105) (establishment of body hair planar orientation), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0005544](http://purl.obolibrary.org/obo/GO_0005544) (calcium-dependent phospholipid binding), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding), [GO:0021954](http://purl.obolibrary.org/obo/GO_0021954) (central nervous system neuron development), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0000221](http://purl.obolibrary.org/obo/GO_0000221) (vacuolar proton-transporting V-type ATPase, V1 domain), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0001786](http://purl.obolibrary.org/obo/GO_0001786) (phosphatidylserine binding), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0051482](http://purl.obolibrary.org/obo/GO_0051482) (positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0034220](http://purl.obolibrary.org/obo/GO_0034220) (ion transmembrane transport), [GO:0008076](http://purl.obolibrary.org/obo/GO_0008076) (voltage-gated potassium channel complex), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0010701](http://purl.obolibrary.org/obo/GO_0010701) (positive regulation of norepinephrine secretion), [GO:1990816](http://purl.obolibrary.org/obo/GO_1990816) (vacuole-mitochondrion membrane contact site), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0032395](http://purl.obolibrary.org/obo/GO_0032395) (MHC class II receptor activity), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0032386](http://purl.obolibrary.org/obo/GO_0032386) (regulation of intracellular transport), [GO:0035775](http://purl.obolibrary.org/obo/GO_0035775) (pronephric glomerulus morphogenesis), [GO:0010494](http://purl.obolibrary.org/obo/GO_0010494) (cytoplasmic stress granule), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0002072](http://purl.obolibrary.org/obo/GO_0002072) (optic cup morphogenesis involved in camera-type eye development), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:0042734](http://purl.obolibrary.org/obo/GO_0042734) (presynaptic membrane), [GO:0015992](http://purl.obolibrary.org/obo/GO_0015992) (proton transport), [GO:0015991](http://purl.obolibrary.org/obo/GO_0015991) (ATP hydrolysis coupled proton transport), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0033180](http://purl.obolibrary.org/obo/GO_0033180) (proton-transporting V-type ATPase, V1 domain), [GO:1902906](http://purl.obolibrary.org/obo/GO_1902906) (proteasome storage granule assembly), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0034705](http://purl.obolibrary.org/obo/GO_0034705) (potassium channel complex), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0050808](http://purl.obolibrary.org/obo/GO_0050808) (synapse organization), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0000155](http://purl.obolibrary.org/obo/GO_0000155) (phosphorelay sensor kinase activity), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0072015](http://purl.obolibrary.org/obo/GO_0072015) (glomerular visceral epithelial cell development), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0004629](http://purl.obolibrary.org/obo/GO_0004629) (phospholipase C activity), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0031424](http://purl.obolibrary.org/obo/GO_0031424) (keratinization), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0005251](http://purl.obolibrary.org/obo/GO_0005251) (delayed rectifier potassium channel activity), [GO:0045104](http://purl.obolibrary.org/obo/GO_0045104) (intermediate filament cytoskeleton organization), [GO:0045109](http://purl.obolibrary.org/obo/GO_0045109) (intermediate filament organization), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0005249](http://purl.obolibrary.org/obo/GO_0005249) (voltage-gated potassium channel activity), [GO:0044140](http://purl.obolibrary.org/obo/GO_0044140) (negative regulation of growth of symbiont on or near host surface), [GO:0004957](http://purl.obolibrary.org/obo/GO_0004957) (prostaglandin E receptor activity), [GO:0045111](http://purl.obolibrary.org/obo/GO_0045111) (intermediate filament cytoskeleton), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0060071](http://purl.obolibrary.org/obo/GO_0060071) (Wnt signaling pathway, planar cell polarity pathway), [GO:0070300](http://purl.obolibrary.org/obo/GO_0070300) (phosphatidic acid binding), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0061386](http://purl.obolibrary.org/obo/GO_0061386) (closure of optic fissure), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0051480](http://purl.obolibrary.org/obo/GO_0051480) (regulation of cytosolic calcium ion concentration), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0005267](http://purl.obolibrary.org/obo/GO_0005267) (potassium channel activity), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:1902936](http://purl.obolibrary.org/obo/GO_1902936) (phosphatidylinositol bisphosphate binding), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030673](http://purl.obolibrary.org/obo/GO_0030673) (axolemma), [GO:0035567](http://purl.obolibrary.org/obo/GO_0035567) (non-canonical Wnt signaling pathway), 

**Class expressions from DL-Learner:**

- Thing 56.33%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.51%
- [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane) 50.51%
- [GO:0042734](http://purl.obolibrary.org/obo/GO_0042734) (presynaptic membrane) 50.51%
- [GO:0030673](http://purl.obolibrary.org/obo/GO_0030673) (axolemma) 50.51%
- [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane) 50.51%
- [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane) 50.51%
- [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane) 50.51%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.51%
- [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane) 50.51%
- [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane) 50.51%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 50.51%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane) 50.51%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 35.87%
- [GO:0098852](http://purl.obolibrary.org/obo/GO_0098852) (lytic vacuole membrane) 35.87%


